NCT03979482View on ClinicalTrials.gov

Skeletal Muscle Mitochondrial Abnormalities and the Metabolic Syndrome in PAH

CompletedOBSERVATIONAL

Enrollment

30

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

April 15, 2023

Study Completion Date

April 15, 2023

Conditions

Pulmonary Artery Hypertension

Trial Locations (1)

G1V 4G5

IUCPQ-UL, Québec

All Listed Sponsors

lead

Laval University

OTHER

NCT03979482 - Skeletal Muscle Mitochondrial Abnormalities and the Metabolic Syndrome in PAH | Biotech Hunter | Biotech Hunter